To investigate the real-life safety profile of the BNT162b2 COVID-19 vaccine in people with myasthenia gravis.
Latest Information Update: 18 Apr 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 18 Apr 2022 New trial record
- 01 Mar 2022 Results published in the Neuromuscular Disorders